ANN THOMAS: Open Payments
NPI 1891723425 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 40 payments from 16 companies in 2025. Trend: 2023 $1,300 · 2024 $1,579 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $123 |
| Endo USA, Inc. | 7 | $113 |
| PFIZER INC. | 5 | $106 |
| Blue Earth Diagnostics | 3 | $63 |
| TOLMAR, INC. | 2 | $60 |
| Astellas Pharma US Inc | 3 | $57 |
| UROGEN PHARMA, INC. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Janssen Biotech, Inc. | 2 | $49 |
Products named: XTANDI, GEMTESA, AVEED, POSLUMA, ELIGARD, JELMYTO, ADSTILADRIN, ERLEADA.
Industry payments across NC — which companies pay providers there.
